Impaired Hypoglycemic Awareness

2

Review clinical trials related to Impaired Hypoglycemic Awareness. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia.

Participants needed: 52
Trial details
Phase: Phase 3Age: 18-65Biological sex: AllType: InterventionalSponsor: Vertex Pharmaceuticals IncorporatedUpdated: Jun 30, 2026Locations: 29
Eligibility criteria

Clinical history of T1D with > 5 years of duration of insulin dependence [+3]

Status: Recruiting

A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes

This study will evaluate the safety, tolerability and efficacy of E-islet 01 in participants with Type 1 diabetes mellitus (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia

Participants needed: 21
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: EndoCell Therapeutics, Inc.Updated: Aug 22, 2025Locations: 1
Eligibility criteria

Clinical history of Type 1 Diabetes with > 5 years of duration [+5]

Uncontrolled systemic infections, including but not limited to pulmonary tubercu... [+3]